Disease/Infection News

RSS

Combination of antibiotics and peptides could eliminate parasite-causing leishmaniasis

A combination of peptides and antibiotics could be key to eliminating the parasite causing leishmaniasis and avoiding the toxicity to people and animals caused by current drugs.

16 Oct 2020

New diagnostic test detects and identifies SARS-CoV-2 virus in less than five minutes

Scientists from Oxford University’s Department of Physics have developed an extremely rapid diagnostic test that detects and identifies viruses in less than five minutes.

16 Oct 2020

Control trial proves effectiveness of repurposed drugs for COVID-19 treatment

In just six months, the world's largest randomized control trial on COVID-19 therapeutics has generated conclusive evidence on the effectiveness of repurposed drugs for the treatment of COVID-19.

16 Oct 2020

New article explores the endemic potential of COVID-19 virus

A new article by Columbia Mailman School researchers Jeffrey Shaman and Marta Galanti explores the potential for the COVID-19 virus to become endemic, a regular feature producing recurring outbreaks in humans.

16 Oct 2020

New book highlights climate crisis, urges governments for a sustainable future

When COVID-19 announced its catastrophic presence in the global theatre it temporarily upstaged the climate crisis which showed we were on the path to environmental and social disaster.

16 Oct 2020

Novel method can predict influenza epidemics

Researchers at Linköping University, Sweden, have developed a unique method to predict influenza epidemics by combining several sources of data.

16 Oct 2020

CRISPR-based engineered cell lines can accelerate potential treatment targets for SARS-CoV-2

Synthego, the genome engineering company, has collaborated with The Krogan Lab, a world-renowned scientific research unit at the Quantitative Biosciences Institute (QBI) at the University of California, San Francisco (UCSF), to deliver multiple CRISPR-based engineered cell lines to accelerate the study of potential treatment targets for SARS-CoV-2, the novel coronavirus that causes COVID-19 disease.

16 Oct 2020

Impact of COVID-19 on Australians with hypertension

Ten months into the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is unclear how people with hypertension are coping, given their increased risk. A retrospective case-control study compared people with hypertension to matched healthy controls during COVID-19 lockdown to determine whether they have higher risk perceptions, anxiety, and prevention intentions. The study is published on the preprint server medRxiv* in October 2020.

16 Oct 2020

Scientists discover a novel antiviral strategy for treating COVID-19

A research team led by Professor Hongzhe SUN, Norman & Cecilia Yip Professor in Bioinorganic Chemistry, Department of Chemistry, Faculty of Science, and Professor Kwok Yung YUEN, Henry Fok Professor in Infectious Diseases, Department of Microbiology, Li Ka Shing Faculty of Medicine of the University of Hong Kong (HKU), has discovered a novel antiviral strategy for treatment of COVID-19.

16 Oct 2020

Rapid development of functionally diverse SARS-COV-2 mouse monoclonal antibodies

Now, a recent study published on the preprint server bioRxiv in October 2020 reports the development of a rapid process for generating high-affinity mouse mAbs, and their functional attributes.

16 Oct 2020

Exposure to ancient parasites may be linked to humans’ response to coronavirus

Why are some people more resilient to viruses than others? The answer has eluded scientists for centuries and, in the age of COVID-19, has come to represent one of the holy grails of biomedical research.

16 Oct 2020

NFID issues new report detailing risks of co-infection with flu and COVID-19 in vulnerable adults

The National Foundation for Infectious Diseases (NFID) issued a new Call to Action report detailing the risks of co-infection with influenza (flu) and COVID-19 in adults with chronic health conditions, and the importance of flu vaccination during the 2020-2021 season.

16 Oct 2020

High-titer convalescent plasma reduced COVID-19 symptom severity in green monkeys

As scientists scramble to find effective vaccines and antivirals for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recent study published on the preprint server bioRxiv in October 2020 reports that the use of convalescent plasma to treat COVID-19 disease early in the course of the illness may be among the best available strategies at present.

16 Oct 2020

Scientists reveal host pathways hijacked by three lethal coronaviruses

Seeking to inform development of drugs effective against multiple pathogenic human coronaviruses, David E. Gordon and colleagues compared host interactions of MERS-CoV, SARS-CoV-1 and SARS-CoV-2, uncovering host pathways commonly hijacked by all three.

16 Oct 2020

Sexually active students more likely to use STI self-testing services

Sexually transmitted infections (STIs) are at record levels in the United States, with the Centers for Disease Control and Prevention reporting recent "steep and sustained" increases.

16 Oct 2020

Sanofi Translate Bio MRT5500 COVID-19 vaccine shows promise in preclinical trials

The COVID-19 pandemic is threatening to come back in greater intensity during the winter and fall. Faced with this threat, vaccine development efforts are entering a phase of renewed focus, attempting to identify antigens capable of eliciting protective levels of neutralizing antibodies. A new study published on the preprint server bioRxiv* in October 2020 reports on a novel mRNA vaccine candidate's performance in two animal models.

16 Oct 2020

Study aims to understand the impact of COVID-19 pandemic on Canadian veterans and their spouses

Lawson Health Research Institute and the Centre of Excellence on Post-Traumatic Stress Disorder (PTSD) are partnering with a population at high risk of mental illness - Canadian Veterans and spouses of Canadian Veterans - to study how they have been impacted by the COVID-19 pandemic.

15 Oct 2020

Should Australia re-open international borders?

Australian scientist Jessica Liebig from the Commonwealth Scientific and Industrial Research Organisation (CSIRO), along with fellow researchers at the Queensland University of Technology and the University of New South Wales, studied the risks involved in re-opening the international borders for travelers to Australia.

15 Oct 2020

Mendelian randomization helps evaluate impact of circulating proteins in COVID-19

Researchers identify circulating proteins influencing COVID-19 susceptibility and severity by employing a large-scale two-sample Mendelian randomization (MR) study.

15 Oct 2020

COVID-19 can cause sudden permanent hearing loss in rare cases

Many complications have been reported, including heart disease and prolonged respiratory issues in a group of people called “long-haulers.” Now, a new worrying finding shows that COVID-19 can cause sudden and irreversible hearing loss in patients.

15 Oct 2020

Disease/Infection News

Combination of antibiotics and peptides could eliminate parasite-causing leishmaniasis

New diagnostic test detects and identifies SARS-CoV-2 virus in less than five minutes

Control trial proves effectiveness of repurposed drugs for COVID-19 treatment

New article explores the endemic potential of COVID-19 virus

New book highlights climate crisis, urges governments for a sustainable future

Novel method can predict influenza epidemics

CRISPR-based engineered cell lines can accelerate potential treatment targets for SARS-CoV-2

Impact of COVID-19 on Australians with hypertension

Scientists discover a novel antiviral strategy for treating COVID-19

Rapid development of functionally diverse SARS-COV-2 mouse monoclonal antibodies

Exposure to ancient parasites may be linked to humans’ response to coronavirus

NFID issues new report detailing risks of co-infection with flu and COVID-19 in vulnerable adults

High-titer convalescent plasma reduced COVID-19 symptom severity in green monkeys

Scientists reveal host pathways hijacked by three lethal coronaviruses

Sexually active students more likely to use STI self-testing services

Sanofi Translate Bio MRT5500 COVID-19 vaccine shows promise in preclinical trials

Study aims to understand the impact of COVID-19 pandemic on Canadian veterans and their spouses

Should Australia re-open international borders?

Mendelian randomization helps evaluate impact of circulating proteins in COVID-19

COVID-19 can cause sudden permanent hearing loss in rare cases

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News